Disclosures for "A Real-world Comparative Study on the Efficacy and Safety of Inebilizumab versus Rituximab in the Treatment of Neuromyelitis Optica Spectrum Disorder"
-
The institution of Dr. Zhu has received research support from China.
-
The institution of Miss Song has received research support from National Natural Science Foundation of China.
-
The institution of Hongbo Liu has received research support from China.